Johnson & Johnson Consumer Inc. Presents 21 Scientific Posters/Abstracts At The 2017 American Academy of Dermatology Annual Meeting

Neonatal Microbiome Study to be Presented at Late-Breaking Research Forum

News provided by

Mar 03, 2017, 07:00 ET

SKILLMAN, N.J., March 3, 2017 /PRNewswire/ -- As a global leader in scientifically driven skincare, Johnson & Johnson Consumer Inc. will present 21 Posters/Abstracts at this year's American Academy of Dermatology (AAD) Annual Meeting in Orlando, FL, March 3-7, 2017. The research includes studies in photoprotection, light therapy for acne, atopic dermatitis and skin microbiome.

"As the research shared at this meeting shows, our scientists study skin health around the world and across a lifetime, from birth to maturity," said Jennifer Zhu, Vice President, Global Beauty R&D at Johnson & Johnson Consumer Inc. "We are committed to developing transformative solutions for common skincare concerns, while adhering to a high standard of clinical efficacy and superior aesthetics."

Of note, Longitudinal Development of the Skin Microbiome During the Neonatal Period (#5324) will be presented at the Late-Breaking Research Forum (Clinical Studies/Pediatric) on Saturday, March 4 from 1:00 – 3:00 PM EST (F072), by Kimberly Capone, PhD, Research Fellow at Johnson & Johnson Consumer Inc.

"Our team is committed to better understanding the role of the microbiome across skin health in a scientifically rigorous way in order to provide truly disruptive approaches to treating skin issues," said Ms. Zhu. "This area of research delivers insights that are relevant to our current business, as well as to our long-term pipeline for both pediatric and adult product development."

Scientific Posters include evaluations of high-SPF sunscreen in real-world settings, as well as an assessment of efficacy, tolerance and mode of action for low-level blue/red light therapy in treatment of acne.

All abstracts will be available for online viewing at the AAD meeting starting 7:00AM EST on March 3, 2017.

Photoprotection: including sunscreen efficacy in actual use settings, Zinc Oxide technology, anti-aging benefits

#4389	High-SPF Sunscreen Provides Significant Clinical Benefit in Actual-Use Conditions: SPF 100+ Is More Effective Than SPF 50+

#4388	High-SPF Sunscreen Provides Significantly Better Sunburn Protection and Reduces Cumulative Skin Damage During a MultiDay Beach Clinical Study: SPF 100+ Is More Effective Than SPF 50+

#4440	Sun Protection Efficacy by Shade

#4439	Modern Sunscreen Formulations Do Not Interfere with Sweating During Exercise

#4458	Microscopic Evaluation of ZnO Sunscreens In Vivo

#4438	Zinc Oxide Technology and Superior UVA Protection

#4501	Objective and Self-Perceived Anti-Aging Skin Benefits Using a Daily Facial Photostable, Broad-Spectrum Sunscreen Product Over One Year on Asian Subjects


Acne: including low-level red/blue light therapy, cleansing and skin barrier

#4436	A Multicenter, Evaluator-Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatments on Subjects with Mild to Moderate Acne Vulgaris

#4441	Low-Level Red LED Light Inhibits Inflammation Induced by Unsaturated Fatty Acid In Vitro

#4377	Utilization of 440 nm Blue Light to Target Propionibacterium acnes for Treating Acne Vulgaris

#5651	Dermatologists' Perceptions of Blue-Red Light Acne Phototherapies

#5560	Physicians' Attitudes Toward Home-based Devices for Acne

#4402	Efficacy and Skin Barrier Benefits of a Novel Acne Cleanser with Polymeric Surfactant Technology


Atopic Dermatitis and Severe Dry Skin

#4390	A Clinical Trial to Determine the Therapeutic Benefit of an Investigational Over-the-Counter Cream on Dry, Itchy Skin of Adults and Children with Atopic Dermatitis

#4391	Compliance Usage Rate and Efficacy of a Coconut-Scented Lotion Versus a Fragrance-Free Lotion in Female Subjects with Moderate to Severe Dry Skin With Itch

#4392	A Clinical Trial to Evaluate the Efficacy of an OTC Colloidal Oatmeal Skin Protectant Cream in the Management of Mild to Moderate Atopic Dermatitis in Infants and Toddlers


Hydration and Skin Barrier

#4442	A Unique Gel Matrix Moisturizer Delivers Deep Hydration Resulting in Significant Clinical Improvement in Radiance and Texture


Aesthetic Dermatology

#5127	A Multifaceted Calming Serum Significantly Improves Facial Redness and Signs of Aging in Combination with a PHA/Bionic Acid Skincare Regimen

#5568	A Topical Effervescent Mask Provides Oxygen with Polyhydroxy/Bionic Acids to Help Calm Skin Immediately After Non- Invasive Cosmetic Procedures

#5118	Advanced, Physician-Strength Retinol Peel Improves the Appearance of Fine Lines, Wrinkles, Skin Firmness and Overall Complexion Brightness

About Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Inc., based in Skillman, NJ, is one of the world's largest consumer health and personal care products companies. Our consumer companies produce many of the world's most trusted brands, among them JOHNSON'S® Baby, BAND-AID®, NEUTROGENA®, TYLENOL®, MOTRIN®, and LISTERINE®. Each one of our consumer businesses embraces innovative science to create products that anticipate consumer needs and create experiences that help them live healthy, vibrant lives.

SOURCE Johnson & Johnson Consumer Inc.